Varicella vaccine effectiveness in the US vaccination program: a review.
about
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsMicrobiology laboratory and the management of mother-child varicella-zoster virus infectionReview of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project dataEffectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.Trends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.The impact of varicella vaccination on varicella-related hospitalization rates: global data reviewVaricella vaccination in Europe - taking the practical approach.Varicella and varicella vaccination in South KoreaAn outbreak of varicella among schoolchildren in Taipei.Primary versus secondary failure after varicella vaccination: implications for interval between 2 dosesSuccesses and challenges in varicella vaccineFirst reported cluster of overwhelming group A streptococcal septicaemia and associated chickenpox infection in the UKPerspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.Effectiveness of 2 doses of varicella vaccine in children.Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011Evidence-based clinical guidelines for immigrants and refugees.Clinical manifestations of herpes zoster, its comorbidities, and its complications in north of iran from 2007 to 2013Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based StudyVaricella disease in Beijing in the era of voluntary vaccination, 2007 to 2010.Single-dose varicella vaccine effectiveness in school settings in China.Antibody induced by one-dose varicella vaccine soon became weak in children: evidence from a cross-sectional seroepidemiological survey in Beijing, PRCTwo-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school studentsVaricella paediatric hospitalisations in Belgium: a 1-year national surveyHerpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Varicella hospitalizations in Los Angeles during the varicella vaccination era, 2003-2011: are they preventable?Vaccine effectiveness evaluation during a varicella outbreak among children of primary schools and day-care centers in a region which adopted UMVAn Evaluation of Voluntary Varicella Vaccination Coverage in Zhejiang Province, East China.Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccinationEfficacy of varicella (VZV) vaccination: an update for the clinician.Varicella Infection Complicated by Group A Beta-Hemolytic Streptococcal Retropharyngeal Abscess.Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre, Spain.Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models.Impact of methodology on the results of economic evaluations of varicella vaccination programs: is it important for decision-making?Molecular studies of the Oka varicella vaccine.Immunisation led to a major reduction in paediatric patients hospitalised because of the varicella infection in Israel.Epidemiological characteristics of breakthrough varicella infection during varicella outbreaks in Shanghai, 2008-2014.β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination.Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.
P2860
Q24193819-021350C3-2C98-48C1-A7BE-D7E48D2D7F04Q26738745-26208377-DA16-46B5-8890-9900459908B9Q26863614-A7983A22-07CB-41BE-8706-D01C3B007217Q30419896-CEBB52A9-5C76-4A3A-A055-D95A80406E42Q30899562-F5E9BC0A-62DC-4CF5-8F47-BAE7A6269511Q31056695-639148F5-AD5E-4D5A-B75A-98375A6B110CQ33454919-482C51F1-C7EF-4060-BF8C-3B863F738C72Q33601820-5D2AD6C2-AA6A-44BE-A1A8-9ECFD1A0C9C8Q33870506-D4D19867-9B1D-4E73-BE08-99D55B5C3EEBQ33880341-C1E6AA86-A87F-49E7-A2B9-8C8C8BF0D69AQ34416710-69E120EC-1BFF-48D9-A00D-1AF8D750DC7FQ34535708-088DD283-0F7D-4C37-A0C6-7D4DE9861727Q34683751-76FB9DC4-DD37-4A27-A48C-6A9AC800979EQ34763888-70335627-B624-4EDC-B8D5-4D059CBA7D82Q34788015-6EE2B1B3-B64D-47E2-8949-D2C4809A5EBCQ35201293-F78A8780-4A4E-4A43-AA33-6BB41E1E658DQ35373216-FCD7B521-5898-4482-9B00-95096EEF126CQ35692355-B76A2C9F-ECD2-4867-9C03-32662406A5B9Q36136682-CBBC1A2A-D1DA-40D3-8DE4-F94FB31964F2Q36161043-12A0CAAA-0B82-40BF-B137-DF313123F53DQ36270547-F5D5B937-00E9-466D-B358-2F6AA37CC61DQ36358276-4D7A456F-596C-4F01-890B-4DBA828BF2E5Q36475701-40B0C751-0380-41C6-BB27-BE2F8190CB00Q36824210-58107BD6-7AE2-466E-8C95-9740CEE6A451Q36865170-0B83CA05-8C22-4C1F-BCA2-C868A4249C3EQ36887989-E715045A-99E9-44F2-B1E4-9B01E9943571Q37044741-5C454107-B683-4607-972F-2BAED152E6BFQ37135445-8269D3A3-FD6E-4196-B76F-D78659219695Q37158220-38B0593D-A9F4-4417-ADD4-83F757151DAEQ37249885-E305A570-069F-4009-8B08-C58B84DDF7D1Q37387611-D3B82C19-C521-45DD-B6E1-DEDE57425C65Q37505437-776552F7-5B6A-4F5C-85C2-25647004CD63Q37625435-77D94724-18BC-48AF-A11B-F036D437DD24Q37660930-DBFD9418-C93A-48C5-874D-4E31B41AA3DFQ37932527-F1E9ED4A-0DF4-4995-8255-753EC750960DQ38680477-77F4CF8F-0A34-49B3-8DDC-2BC8B660CE9AQ38818159-8AACD6ED-0D54-4F43-90B4-A4DF4C0E4C81Q38972819-029D4F99-A96E-4B1D-A080-7394C44E7D03Q38992374-22103EA6-B339-4664-8C9B-B1EB661A27ACQ39128973-C548BBED-6FEA-45D2-BF54-09E49E5A7FF7
P2860
Varicella vaccine effectiveness in the US vaccination program: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Varicella vaccine effectiveness in the US vaccination program: a review.
@en
Varicella vaccine effectiveness in the US vaccination program: a review.
@nl
type
label
Varicella vaccine effectiveness in the US vaccination program: a review.
@en
Varicella vaccine effectiveness in the US vaccination program: a review.
@nl
prefLabel
Varicella vaccine effectiveness in the US vaccination program: a review.
@en
Varicella vaccine effectiveness in the US vaccination program: a review.
@nl
P2093
P2860
P356
P1476
Varicella vaccine effectiveness in the US vaccination program: a review.
@en
P2093
Jane F Seward
Marietta Vázquez
Mona Marin
P2860
P356
10.1086/522145
P407
P478
197 Suppl 2
P577
2008-03-01T00:00:00Z